Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MAT2203
DRUG
2 trials
Sponsors
Matinas BioPharma Nanotechnologies, Inc.
Conditions
Cryptococcal Meningitis
Phase 1
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
Completed
NCT04031833
Matinas BioPharma Nanotechnologies, Inc.
Cryptococcal Meningitis
Start: 2019-10-24
End: 2023-02-15
Updated: 2023-03-31
Phase 3
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
NCT05541107
Matinas BioPharma Nanotechnologies, Inc.
Cryptococcal Meningitis
Start: 2023-01-31
End: 2025-01-31
Target: 270
Updated: 2022-09-15
Related Papers
Experience of research nurses with oral encochleated amphotericin B for treatment of cryptococcal meningitis in a resource-limited setting.
2025-07-15
1 citations
Experiences, challenges, gaps, and strategies for counselling persons presenting with advanced HIV-associated meningitis in Uganda.
2025-02-19
1 citations
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
Clinical Infectious Diseases
2023-08-22
53 citations
Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B.
2020-09-21
40 citations